158 related articles for article (PubMed ID: 22807330)
1. Ribonucleoside 3'-phosphates as pro-moieties for an orally administered drug.
Palte MJ; Davis AK; McGrath NA; Spiegel CA; Raines RT
ChemMedChem; 2012 Aug; 7(8):1361-4. PubMed ID: 22807330
[No Abstract] [Full Text] [Related]
2. Mechanisms of Bacteroides fragilis resistance to metronidazole.
Ghotaslou R; Bannazadeh Baghi H; Alizadeh N; Yekani M; Arbabi S; Memar MY
Infect Genet Evol; 2018 Oct; 64():156-163. PubMed ID: 29936037
[TBL] [Abstract][Full Text] [Related]
3. Bacteroides fragilis resistant to metronidazole after long-term therapy.
Ingham HR; Eaton S; Venables CW; Adams PC
Lancet; 1978 Jan; 1(8057):214. PubMed ID: 74641
[No Abstract] [Full Text] [Related]
4. Bacteraemia due to Bacteroides fragilis with reduced susceptibility to metronidazole.
Elsaghier AA; Brazier JS; James EA
J Antimicrob Chemother; 2003 Jun; 51(6):1436-7. PubMed ID: 12746378
[No Abstract] [Full Text] [Related]
5. Enhanced pathogenicity of susceptible strains of the Bacteroides fragilis group subjected to low doses of metronidazole.
Diniz CG; Arantes RM; Cara DC; Lima FL; Nicoli JR; Carvalho MA; Farias LM
Microbes Infect; 2003 Jan; 5(1):19-26. PubMed ID: 12593969
[TBL] [Abstract][Full Text] [Related]
6. Levofloxacin plus metronidazole administered once daily versus moxifloxacin monotherapy against a mixed infection of Escherichia coli and Bacteroides fragilis in an in vitro pharmacodynamic model.
Hermsen ED; Hovde LB; Sprandel KA; Rodvold KA; Rotschafer JC
Antimicrob Agents Chemother; 2005 Feb; 49(2):685-9. PubMed ID: 15673752
[TBL] [Abstract][Full Text] [Related]
7. Metronidazole resistant Bacteroides fragilis infection of a prosthetic hip joint.
Hickey MM; Davies UM; Dave J; Vogler M; Wall RA
J Infect; 1990 Mar; 20(2):129-33. PubMed ID: 2319145
[TBL] [Abstract][Full Text] [Related]
8. The underappreciated in vitro activity of tedizolid against Bacteroides fragilis species, including strains resistant to metronidazole and carbapenems.
Goldstein EJ; Citron DM; Tyrrell KL; Leoncio ES; Merriam CV
Anaerobe; 2017 Feb; 43():1-3. PubMed ID: 27713022
[TBL] [Abstract][Full Text] [Related]
9. [Bacteriological and clinical studies on metronidazole in Bacteroides fragilis infections (author's transl)].
Shimada K; Inamatsu T; Sato K
Jpn J Antibiot; 1979 Feb; 32(2):191-4. PubMed ID: 439390
[TBL] [Abstract][Full Text] [Related]
10. Bacteroides fragilis meningitis successfully treated with metronidazole after a previous failure with thiamphenicol.
Soriano F; Aguado JM; Tornero J; Fernandez-Guerrero ML; Gómez-Garcés JL
J Clin Microbiol; 1986 Sep; 24(3):472-3. PubMed ID: 3760141
[TBL] [Abstract][Full Text] [Related]
11. Relative efficacy and critical interval of antimicrobial agents in experimental infections involving bacteroides fragilis.
Bartlett JG; Dezfulian M; Joiner K
Arch Surg; 1983 Feb; 118(2):181-4. PubMed ID: 6849635
[TBL] [Abstract][Full Text] [Related]
12. Relative antibacterial efficacy of clindamycin and metronidazole against Bacteroides fragilis in vitro and in experimentally infected mice.
Dijkmans BA; Vaishnav J; Mattie H
Chemotherapy; 1985; 31(4):297-303. PubMed ID: 4028873
[TBL] [Abstract][Full Text] [Related]
13. Effect of antibiotics on the prevention of experimental Bacteroides fragilis endocarditis.
Goldman PL; Durack DT; Petersdorf RG
Antimicrob Agents Chemother; 1978 Nov; 14(5):755-60. PubMed ID: 727764
[TBL] [Abstract][Full Text] [Related]
14. Metronidazole treatment of Bacteroides fragilis infections.
Melo JC; Raff MJ; Wunderlich HF; Chun CH; Summersgill JT; Varghese R
Am J Med Sci; 1980; 280(3):143-9. PubMed ID: 7457495
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial resistance in the Bacteroides fragilis group in faecal microbiota from healthy Danish children.
Sydenham TV; Jensen BH; Petersen AM; Krogfelt KA; Justesen US
Int J Antimicrob Agents; 2017 May; 49(5):573-578. PubMed ID: 28366659
[TBL] [Abstract][Full Text] [Related]
16. [Appearance of metronidazole resistance in Bacteroides fragilis].
Chardon H; Ratignier A; Luneau R; Garrigues B
Nouv Presse Med; 1977 Jun; 6(24):2165. PubMed ID: 905136
[No Abstract] [Full Text] [Related]
17. Bacteroides fragilis resistant to both metronidazole and imipenem.
Lamothe F; Fijalkowski C; Malouin F; Bourgault AM; Delorme L
J Antimicrob Chemother; 1986 Nov; 18(5):642-3. PubMed ID: 3468099
[No Abstract] [Full Text] [Related]
18. Resistance trends of the Bacteroides fragilis group over a 10-year period, 1997 to 2006, in Madrid, Spain.
Betriu C; Culebras E; Gómez M; López F; Rodríguez-Avial I; Picazo JJ
Antimicrob Agents Chemother; 2008 Jul; 52(7):2686-90. PubMed ID: 18474575
[TBL] [Abstract][Full Text] [Related]
19. Molecular study on metronidazole resistance in Bacteroides fragilis group isolates from a South Indian tertiary care center.
Jahan L; Biswas R
Anaerobe; 2023 Apr; 80():102692. PubMed ID: 36642289
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic efficacy of moxifloxacin, a new quinolone, in the treatment of experimental intra-abdominal abscesses induced by Bacteroides fragilis in mice.
Thadepalli H; Chuah SK; Gollapudi S
Chemotherapy; 2004 Jun; 50(2):76-80. PubMed ID: 15211081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
